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A B S T R A C T
On a population basis, there is a gradual decline in vitamin D status (plasma 25(OH)D) throughout winter.
We developed a mathematical model to predict the population winter plasma 25(OH)D concentration
longitudinally, using age-speciﬁc values for 25(OH)D expenditure (25(OH)D3 t1/2), cross-sectional plasma
25(OH)D concentration and vitamin D intake (VDI) data from older (70+ years; n = 492) and younger
adults (18–69 years; n = 448) participating in the UK National Diet and Nutrition Survey. From this model,
the population VDI required to maintain the mean plasma 25(OH)D at a set concentration can be derived.
As expected, both predicted and measured population 25(OH)D (mean (95%CI)) progressively declined
from September to March (from 51 (40–61) to 38 (36–41) nmol/L (predicted) vs 38 (27–48) nmol/L
(measured) in older people and from 59 (54–65) to 34 (31–37) nmol/L (predicted) vs 37 (31–44) nmol/L
(measured) in younger people). The predicted and measured mean values closely matched. The predicted
VDIs required to maintain mean winter plasma 25(OH)D at 50 nmol/L at the population level were 10 (0–
20) to 11 (9–14) and 11 (6–16) to 13(11–16) mg/d for older and younger adults, respectively dependent on
the month. In conclusion, a prediction model accounting for 25(OH)D3 t1/2, VDI and scaling factor for the
25(OH)D response to VDI, closely predicts measured population winter values. Reﬁnements of this model
may include speciﬁc scaling factors accounting for the 25(OH)D response at different VDIs and as
inﬂuenced by body composition and speciﬁc values for 25(OH)D3 t1/2 dependent on host factors such as
kidney function. This model may help to reduce the need for longitudinal measurements.
ã 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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The plasma concentration of 25 hydroxy vitamin D (25(OH)D)
reﬂects the supply from oral intake (in the form of vitamin D2 and
D3 and 25(OH)D3)) and vitamin D3 from endogenous cutaneous
synthesis. In temperate climates (>30N and >30S), no cutaneous
synthesis of vitamin D takes place in the winter months [1].
Therefore, the winter plasma concentration of 25(OH)D is mainly a
function of an individual’s post-summer status, their expenditure
of 25(OH)D and their vitamin D supply through diet. In populations
living in a temperate climate, there is a gradual decline in the mean
vitamin D status from late autumn throughout winter [1–4],
indicating that, on average, the daily vitamin D intake is less than
its daily expenditure. The impact of this circannual cycling of
25(OH)D is uncertain [5], but many advocate that a decrease in
plasma 25(OH)D below the threshold of sufﬁciency (50 nmol/L) or
deﬁciency (30 nmol/L), as deﬁned by The Institute of Medicine* Corresponding author.
E-mail address: inez.schoenmakers@mrc-hnr.cam.ac.uk (I. Schoenmakers).
http://dx.doi.org/10.1016/j.jsbmb.2016.03.015
0960-0760/ã 2016 The Authors. Published by Elsevier Ltd. This is an open access article un(IOM) [6], should be avoided throughout the year to prevent a
winter increase in plasma parathyroid hormone and bone
resorption, although the threshold at which this occurs is disputed
[5–9].
Here we present a mathematical model to predict longitudi-
nally the population plasma 25(OH)D concentration during winter.
Plasma 25(OH)D concentrations and vitamin D intake (VDI) data
from older (70+ years) and younger adults (18–69 years)
participating in the population based UK National Diet and
Nutrition Survey (NDNS) [10,11] and age-speciﬁc values for vitamin
D expenditure measured as 25(OH)D half-life (25(OH)D3 t1/2)
[12,13]. This model was further applied to estimate mathematically
the required vitamin D intake to maintain the population mean
plasma 25(OH)D at a set concentration.
2. Methods
A subset of data from the National Diet and Nutrition Survey
(NDNS) rolling programme (NDNS years 1–3; 2008/9–2010/11)
and the NDNS of people age 65 years and over (1994/1995) was
extracted from the full data sets available from the UK Data Service.der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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collection, age and dietary intakes of vitamin D (VDI) for each
participant. Special permission to include the month of blood
collection was granted (personal communication Public Health
England NDNS project board). Only data of individuals of 18 years
of age and over were selected. Further information about the
survey, how to access the data and to obtain permission for their
use, can be found at https://www.noo.org.uk/data_sources/Nutri-
tion/NDNS and http://www.data-archive.ac.uk. Recruitment of
participants to NDNS, methods of data collection, measurement of
25(OH)D concentration and dietary intake of vitamin D are
described elsewhere [10,11] and available online (http://webarch-
ive.nationalarchives.gov.uk/20130402145952/ http://transparen-
cy.dh.gov.uk/category/statistics/ndns/) and http://www.data-
archive.ac.uk.
In brief, NDNS participants were randomly selected from the UK
population; data were collected from each individual once, i.e. on a
cross-sectional basis. The survey was designed to be nationally
representative. Visits took place throughout the year and the dates
of visits and blood collections were recorded. Written and verbal
consent was obtained from all participants. To ensure anonymity,
the NDNS dataset only contains details about the month of blood
collection not the day; therefore they were all assigned a value 1,
i.e. all September dates were entered in the model as September 1.
A venous blood sample was collected non-fasting and the plasma
25(OH)D concentration was measured using Diasorin (DiaSorin
Ltd, Dartford, UK) Liaison chemiluminesence immune assay (NDNS
year 1–3; 2008/9–2010/11) or Diasorin Radio  immune assay
(NDNS: people age 65 years and over (1994/1995)) in lithium
heparin plasma. Cross-calibration of the two Diasorin assays
showed good agreement and no systematic bias (https://www.gov.
uk/government/statistics/national-diet-and-nutrition-survey-
results-from-years-1-to-4-combined-of-the-rolling-programme-
for-2008-and-2009-to-2011-and-2012). The laboratory perform-
ing these assays was DEQAS accredited.
Participants completed a 4-day weighed food diary of all food
and drink consumed using standardised house hold scales as
described in detail in the above referenced NDNS report and this is
considered to represent habitual nutrient intakes on a population
level [14]. Vitamin D intake was assessed as Vitamin D (<2002) or
the Vitamin D equivalents to include 25(OH)D3 from animal
tissues (>2002) using British food composition tables (http://www.
ifr.ac.uk/fooddatabanks/nutrients.htm#.Unn_QobTQil).
The data set was split by age into a subset of older (70+ years)
and younger adults (18–69 years). For initial inspection of the
data to determine the yearly peak and nadir in the plasma
concentration of 25(OH)D and potential seasonal variation in
vitamin D intake, data for all months were used. For data
modelling, only data of individuals who provided a blood sample
between September and March and had completed a food diary
were used (70+ years; n = 492) and younger adults (18–69 years;
n = 448).
2.1. Mathematical model to predict the population plasma 25(OH)D
concentration in winter
The following mathematical model was developed as modiﬁ-
cation of the algorithm proposed by Diffey [15,16]. Only autumn
and winter values (October to March) were modelled, with plasma
concentrations obtained in September to April as starting value as
explained below. The contribution of cutaneous vitamin D
synthesis was assigned a value of zero. The resulting model gives
the prediction plasma concentration of 25(OH)D at any time point
(t) after a measured value was obtained (which was deﬁned as
t = 0) and contains 2 main components. The ﬁrst component
accounts for the decline in plasma 25(OH)D due to its expenditure,assuming ﬁrst order kinetics. Age-speciﬁc mean values for 25(OH)
D3 t1/2 were used, as experimentally obtained with a stable isotope
technique with LC–MS/MS quantiﬁcation[12,13]. The second term
accounts for the daily increment in plasma 25(OH)D derived from
an individual’s dietary intake of vitamin D and the subsequent
exponential decline of this component, as reﬂected by the sum of
the geometric series. It accounts for the plasma 25(OH)D response
to vitamin D intake (R (oral)), using a ﬁxed dose-response rate (the
scaling factor) and the release of 25(OH)D into plasma of the
fraction stored in tissues.
Plasma 25ðOHÞDðtÞ ¼ ½Plasma 25ðOHÞDðt¼0Þ  ekt
þ ð0:168  VDIÞ  1  e
kt 
1  ek 
  !
In which:
k ¼ ln2
25ðOHÞD3t1=2
in which 25(OH)D3 t1/2 is the age speciﬁc 25(OH)D3 half-life.
t = the number of days since t = 0
VDI is the daily vitamin D intake calculated as the mean of the 4
recorded days
(0.168* VDI)*((1-ekt)/(1-ek)) reﬂects the daily increment in
plasma 25(OH)D due to VDI and the subsequent exponential
decline of this component. The latter was described by the sum of
the geometric series ((1-ekt)/(1-ek)) in which k was used as
deﬁned above.
The conversion factor of 0.168 (R(oral)) was derived from:
R(oral) = S  (1-f)  2t/b + (f  2t/Y) = 0.168
In which:
S was set as = 0.023; S is the scaling factor for the 25(OH)D
plasma response to VDI and was derived from the median
conversion factor from 9 dose-response studies [15].
f is the fraction of vitamin D taken up and stored in tissues = 0.15
b is 25(OH)D3 t1/2 as deﬁned above
Y is tissue half-life of vitamin D = 250 days
The plasma 25(OH)D concentration was expressed in nmol/L;
25(OH)D3 t1/2 in days; VDI in mg/d.
The plasma 25(OH)D concentration for each participant as
measured in NDNS was included in the model as the starting value
(t = 0) and the predicted values were progressively calculated for
each day thereafter, i.e. if a blood sample was collected in
September, predicted data were derived from this month onwards;
if collected in November, predicted values were derived for the
months thereafter only. As a consequence, the number of
individuals included in the model progressively increased at each
month.
The following assumptions were made:
(ii) A linear relationship between the increment in plasma 25
(OH)D and VDI was assumed within the range of vitamin D intakes
observed in this survey. Therefore a ﬁxed value for S was used. This
was based on the meta-regression analyses presented in the IOM
report, describing a biphasic response with a different dose-
response below and over 25 mg/d (1000 IU/d) [6]. This can be
explained by the metabolic conversion of vitamin D to 25(OH)D,
changing from ﬁrst to zero order kinetics due to saturation of the
hepatic 25-hydoxylase [17]. We also did not account for the
potential difference in the response to food based or supplemental
supply of vitamin D [18]. (ii) A constant supply of vitamin D into the
blood stream from the diet and subsequent conversion in 25(OH)D
was assumed; therefore no allowance was made for the delay
between ingestion and plasma appearance of plasma 25(OH)D
and/or peaks in vitamin D intake during speciﬁc time slots and
days. (iii) The plasma 25(OH)D decreases exponentially starting at
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derived from dietary VDI was added as constant at t = 1, 2, 4, days,
etc and subsequently is assumed to decline exponentially in
parallel to the plasma concentration of 25(OH)D. Therefore, this
algorithm is only valid for integer values of t. (iv) Vitamin D intake
as assessed by 4 day diary reﬂects habitual daily intake and there is
no seasonal variation in vitamin D intake during the year. This
assumption was conﬁrmed by inspection of NDNS data (see
results). (v) The term in the original model by Diffey [15], reﬂecting
cutaneous vitamin D synthesis was assigned a value of zero during
the selected autumn and winter months. This term was therefore
removed from the algorithm. This may have underestimated the
vitamin D supply since some cutaneous synthesis may occur in
September [1] with extensive duration of exposure. In addition,
NDNS participants were not asked to refrain from overseas travel
or sunbed use prior to blood sampling. No detailed data on these
exposures are available prior to 2008 and thus could not be
incorporated into the model. This in accordance with the principle
of assumed minimal sun exposure on the population level, applied
by IOM [6].
2.2. Mathematical model to predict the population vitamin D intake
requirement to maintain plasma 25(OH)D concentration at 50 nmol/L
in winter
The daily mean dietary vitamin D intake (in the absence of any
cutaneous synthesized vitamin D), required to maintain the mean
population plasma 25(OH)D at a given concentration from
September to March was derived from the above model. To
illustrate the principle of this model, the threshold for sufﬁciency
as deﬁned by the IOM was chosen, but any threshold may be
modelled. The plasma 25(OH)D concentration was set to be equal
to 50 nmol/L at the end of each month, and can be expressed as the
following algorithm:
VDI ¼ 50  Plasma 25ðOHÞDt¼0  e
kt
½0:168  ð1  ektÞ=ð1  ekÞ
 
This model used the observed value as the plasma concentra-
tion at time zero and the subsequently predicted value in the
previous integer of t as derived from the previous model. It
assumes an intake of vitamin D at the predicted requirement on
each of the preceding days.Fig 1. Measured (mean and 95% CI; white line and grey shading) plasma 25(OH)D conce
(right) and mathematically predicted (mean and 95% CI; black solid line) mean plasma
Data are presented in. The number of plasma 25(OH)D measurements varied by mont3. Results
The yearly peak and nadir in the plasma concentration of 25
(OH)D as measured in NDNS were in September and March,
respectively in both age groups (not presented). The mean (95% CI)
vitamin D intake was 3.8 (3.1, 4.5) and 4.0 (3.0, 4.9) mg/d for the
group of 70y+ and 18–69 y, respectively and was stable throughout
the year (not presented).
The mean (95% CI) measured values in NDNS participants
declined from 51 (40–61) nmol/L in September to 38 (27–48) nmol/
L in March in the older adults and from 59 (54–65) to 37 (31–
44) nmol/L) in younger adults (Fig. 1). There was some deviation
from the expected proﬁle, likely due the variation in number of
participants and the cross-sectional nature of the data. The 95% CIs
of the measured concentrations were higher than the predicted
values, as may be expected from cross-sectional population data.
The predicted values declined from 51 (40–61) to 38 (36–41) nmol/
L in older people and 59 (54–65) to 34 (31–37) nmol/L in younger
people). The widths of the 95% CI of the predicted plasma 25(OH)D
concentrations were inﬂuenced by the progressive increase in the
number of individuals that could be included in the model each
month and were therefore wider in September than in March.
The predicted mean plasma 25(OH)D concentrations, with
consideration of vitamin D intakes and the measured values, fell
within the 95% CI of the measured values, although the predicted
mean was consistently slightly lower than measured values for the
younger group (Fig. 1).
The predicted VDIs required to maintain mean winter plasma
25(OH)D at 50 nmol/L at the population level were 10 (0–20) to 11
(9–14) mg/d and 11 (6–16) to 13 (11–16) mg/d for the group of 70y+
and 18–69 y, respectively, dependent on the month (Fig. 2).
4. Discussion
The predicted longitudinal mean plasma 25(OH)D concentra-
tion during winter months, derived from the mathematical model
closely matched values as measured in the UK population on a
cross-sectional basis. The mathematically estimated vitamin D
intake, required to maintain the population mean plasma 25(OH)D
at 50 nmol/L during winter assuming minimal sun exposure, was
10–11 mg/d and 11–13 mg/d for the older and younger people,
respectively. These values are similar to the mean values estimatedntrations in NDNS for people 70 years of age and over (left) and 18–69 years of age
 25(OH)D concentrations in the population in winter.
h (n = 63–205).
Fig. 2. Mathematically predicted (mean and 95% CI) daily dietary vitamin D intake required to maintain the mean plasma concentration of 25(OH)D at 50 nmol/L on a
population basis for people 70+ years of age and over (left) and 18–69 years of age (right) in winter.
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winter as derived from meta-regression analyses [19,20]. This
analysis utilised the dose-response from several randomised
controlled trials in populations living at latitudes where there is
minimal vitamin D synthesis during the winter months [19,20].
As expected, the 95% CI of the predicted plasma 25(OH)D
concentration was narrower than the population distribution. As a
consequence and additionally due the inherent assumption of the
model that the intake of vitamin D was at the predicted
requirement to maintain a set 25(OH)D concentration on each
of the preceding days, also the predicted VDI had a relatively
narrow 95% CI. Therefore, although this model may aid the
estimation of the mean vitamin D requirement in the population,
for the assessment of the vitamin D intakes to meet the
requirement of majority of the people, the variability in the
population needs to be taken into account [6,19,20].
The model includes a term to account for the expenditure of 25
(OH)D. In contrast to the model proposed by Diffey [15] and several
others that used adapted or slightly different models [19,21,22,18],
the values used in this paper were experimentally determined in
healthy older and younger participants [13,23]. A further alteration
to the original model included the incorporation of a term that
accounts for a continuous inﬂux of vitamin D and 25(OH)D from
dietary sources, whereas Diffey’s algorithm assumed a single bolus
intake. This alteration possibly provides a more realistic proﬁle of
25(OH)D concentrations in observational, population based
studies.
Although the longitudinally predicted values closely corre-
sponded to the cross-sectional values obtained during the winter
months, comparisons with longitudinally collected samples will be
required to validate this mathematical model. Since this model
includes variables reﬂecting vitamin D status, 25(OH)D half-life,
vitamin D intake, and a scaling factor for the relationship between
vitamin D intake and the corresponding change in the plasma 25
(OH)D concentration, the predicted values depend on the accuracy
and precision of these measured variables and how they are
inﬂuenced by population speciﬁc factors. This and other models
[15,19,20,24] rely on a ﬁxed dose-response rate (the scaling factor),
determined from 9 studies [15], which included a wide range of
vitamin D intakes. However, the response of plasma 25(OH)D is
known to be non-linear and the relative increment in plasma 25
(OH)D decreases with an increasing vitamin D dose. In addition, it
has also been suggested that the response may depend on the
source of oral vitamin D [18]. Determination of scaling factors at
corresponding vitamin D intakes and sources may therefore bemore appropriate. Further reﬁnement of this model may be needed
to account for the 25(OH)D response as inﬂuenced by body size and
composition and vitamin D status at baseline [25–27]. Further,
there may be considerable differences in the dose-response
between individuals and population groups, potentially deter-
mined by genetic factors associated with ethnic origin [28]. Further
research is also required to obtain speciﬁc values for 25(OH)D3
half-life dependent on host factors such as age, physiological stage,
ethnicity and kidney function. Also other dietary factors may be
expected to inﬂuence 25(OH)D3 half-life, as shown in animal
models. To date, the limited studies in humans have not shown an
inﬂuence of calcium intake on 25(OH)D3 half-life or vitamin D
status [13,29].
Despite these limitations, this prediction model may improve
the sensitivity of statistical analyses of data obtained in studies in
which participants were included or investigated longitudinally
during different seasons and months of the year. Examples of these
type of studies are randomised controlled trials with vitamin D,
where participants are enrolled in the trial in different seasons. In
these studies the response to supplementation may depend on the
plasma 25(OH)D concentration at baseline, which may be
inﬂuenced by season. In longitudinal studies, the investigation
of the association between vitamin D status and health outcomes
provides a challenge due to its anticipated change with season that
may coincide with the progression of disease processes and/or
physiological changes inducing changing the concentration of 25
(OH)D and other vitamin D metabolites and hormones, for
example during pregnancy. This model may provide an approach
to correct for variations in vitamin D status as caused by the month
or season of sampling.
There are several limitations to this study. This model can only
be used for the prediction of vitamin D status and requirements of
relatively large groups and populations as it cannot sufﬁciently
account for individual differences. The published values for 25(OH)
D half-life were obtained in a relatively small number of
participants, and therefore are unlikely to be fully representative
of the UK population. The model also does not account for the
known time-lag (weeks to months) to reach a new steady state of
the 25(OH)D concentration after the start of vitamin D supple-
mentation.
In conclusion, we developed a mathematical model to predict
longitudinally the mean plasma 25(OH)D concentration on a
population basis during winter, which closely matched values
obtained cross-sectionally in the NDNS survey. This mathematical
model can be used to calculate the mean estimated vitamin D
222 I. Schoenmakers et al. / Journal of Steroid Biochemistry & Molecular Biology 164 (2016) 218–222intake required to maintain the population mean plasma 25(OH)D
concentration at a predetermined concentration.
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